Economic aspects of treating Parkinson's Disease

被引：0
|
作者：
不详
机构：
来源：
REVUE NEUROLOGIQUE | 2000年 / 156卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：215 / 216
页数：2
相关论文
共 50 条
  • [21] Neuropsychiatric aspects of Parkinson's disease
    Marsh, L
    [J]. PSYCHOSOMATICS, 2000, 41 (01) : 15 - 23
  • [22] Psychiatric aspects of Parkinson's disease
    Menza, MA
    [J]. PSYCHIATRIC ANNALS, 2002, 32 (02) : 99 - 104
  • [23] Motor aspects of Parkinson's disease
    Rezak, Michael
    Pallone, Jennifer A.
    Khandhar, Suketu M.
    Marks, William J.
    Rubin, Susan M.
    Kessler, Amy
    Cozzens, Jeffrey W.
    Vergenz, Sandra
    [J]. DM DISEASE-A-MONTH, 2007, 53 (04): : 195 - 251
  • [24] Autoimmune aspects of Parkinson's disease
    Sulzer, D.
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S19 - S19
  • [25] Treatment complications in Parkinson's disease. Is Parkinson's disease dementia worth treating?
    de Fabregues Boixar-Nebot, Oriol
    [J]. REVISTA DE NEUROLOGIA, 2010, 50 : S48 - S50
  • [26] The economic impact of Parkinson's disease
    Findley, Leslie J.
    [J]. PARKINSONISM & RELATED DISORDERS, 2007, 13 : S8 - S12
  • [27] On nicotine's potential role in treating Parkinson's disease
    [J]. Zhang, Z. (conazhang@163.com), 1600, Acta Tabacaria Sinica Editorial Department, 55 Yuetan South Street, Beijing, 100045, China (19):
  • [28] Potential applications of nanomedicine for treating Parkinson's disease
    Shankar, Jyotsna
    Geetha, K. M.
    Wilson, Barnabas
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 66
  • [29] Understanding and Treating Pain Syndromes in Parkinson's Disease
    Gandolfi, Marialuisa
    Geroin, Christian
    Antonini, Angelo
    Smania, Nicola
    Tinazzi, Michele
    [J]. NONMOTOR PARKINSON'S: THE HIDDEN FACE - MANAGEMENT AND THE HIDDEN FACE OF RELATED DISORDERS, 2017, 134 : 827 - 858
  • [30] Glycopyrrolate as inhalation for treating sialorrhea in Parkinson's Disease
    Velzen, L.
    Masselink, J.
    Dorresteijn, L.
    Movig, K.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S667 - S668
12345